chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 17.0
Sex: M
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Loss of consciousness, Pallor
Clinical narrative: Patient alert and oriented prior to vaccine administration. He was able to answer assessment questions. Few seconds after vaccine was given patient was found uncoscious and pale. He regained consciousness a few seconds later.  EMS was called and vitals taken. 131/80 HR 84 98%. Patient regained orientation and was able to walk out of the pharmacy with mother. No further complaints voiced.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site erythema, Injection site warmth, Papule, Skin lesion
Clinical narrative: Pt has developed a round erythematous lesion measuring 10cm X14 cm with a dusky center measuring 4 cm X6cm on the left thigh. Lesion is warm to the touch and has erythematous papule outside of the border of the lesion.   Treatment is to give Benadryl as needed for any rash and apply ice pack as needed to help with swelling. Otherwise continue normal activities.
Age: 66.0
Sex: M
Vaccine: HPV9
Symptoms: Asthenia, Syncope
Clinical narrative: Pt had an episode of syncope shortly after the visit. Pt was aroused and offered juice and crackers. He stated that he felt weak shortly after the episode but once he had juice and crackers he was back up and feeling more like himself.
Sex: U
Vaccine: VARZOS
Symptoms: Blood test normal, Computerised tomogram head normal, Computerised tomogram neck, Diplopia, Headache
Clinical narrative: headaches  within 24 hours, blurry vision within 30 hours, and double vision in 48 hours
Sex: U
Vaccine: VARZOS
Symptoms: Laboratory test normal, Magnetic resonance imaging normal, Vision blurred
Clinical narrative: headaches  within 24 hours, blurry vision within 30 hours, and double vision in 48 hours
Age: 52.0
Sex: F
Vaccine: MMRV
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: INADVERTANTLY GAVE MMRV(PROQUAD) INSTEAD OF MMR TO A PATIENT OF 52 YEARS OLD. PROQUAD IS OUTSIDE AGE RANGE FOR THIS PATIENT. NO REACTIONS NOTED.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given ?beyond use date? of 6/19/23 Not expired. Healthcare provider informed. Moderna contacted and assessed vaccine to be viable. No known health complications for patient.
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given ?beyond use date? of 6/19/23 Not expired. Healthcare provider informed. Moderna contacted and assessed vaccine to be viable. No known health complications for patient.
Age: 63.0
Sex: F
Vaccine: TDAP
Symptoms: Limb discomfort, Mobility decreased, Pain in extremity, Sleep disorder
Clinical narrative: Patient came in with her daughter today, 7/27/23. Daughter says mom received the boostrix vaccine on 3/27/23 and was experiencing left arm discomfort/general pain. She has difficulty raising it above her shoulder, reaching behind her back, and discomfort sleeping on the arm. Daughter says mom started experiencing a sore arm around DAY 3 after the vaccination. When I asked where, the daughter and the mom kept touching the middle of the arm (distance from shoulder to the elbow). I stressed the fact that the vaccine is given on the upper arm. Mom did not wince as the daughter and herself kept pressing on the site. Daughter claims no redness. When touching the arm to determine swelling, the daughter wasn't sure (she was also pressing down the other arm for comparison).
Age: 42.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: painful swollen rash over injection site
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Cerebrovascular accident, Paralysis, Ventricular assist device insertion
Clinical narrative: ABDOMINAL PAIN BIHEMESPHERE STROKE TREATMENT LVAD OUTCOME PARALYZED
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Severe tinnitus in right ear
Age: 12.0
Sex: M
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Wrong vaccine patient was due meningoccol Not the miningoccol B
Age: 12.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Inflammation, Injected limb mobility decreased, Injection site joint pain, Joint range of motion decreased, Loss of personal independence in daily activities
Clinical narrative: Mother called our clinic 7/25/23 and reported that her daughter received Immunizations at her check up 7/11/23 and the injection she received in left arm caused her to have limited range of motion in shoulder joint. Could not lift left arm up high making combing her hair and other activities difficult, couldn't lay flat on back without putting something under left shoulder. Tenderness to left shoulder joint. Mother says in last few days has had some pain up into left side of neck. Mother took her to a urgent care 7/15/23 was prescribed Tizanidine 2mg po q8hr prn. Mother was told it was a sore muscle and inflammation. Mother took patient to Chiropractor 7/25/23. Mother called our clinic for first time to inform us of the issue her daughter was having 7/25/23 and requested a referral be done. Patient set up for follow-up and referral 7/26/23.
Age: 12.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Mobility decreased, Myalgia, Neck pain
Clinical narrative: Mother called our clinic 7/25/23 and reported that her daughter received Immunizations at her check up 7/11/23 and the injection she received in left arm caused her to have limited range of motion in shoulder joint. Could not lift left arm up high making combing her hair and other activities difficult, couldn't lay flat on back without putting something under left shoulder. Tenderness to left shoulder joint. Mother says in last few days has had some pain up into left side of neck. Mother took her to a urgent care 7/15/23 was prescribed Tizanidine 2mg po q8hr prn. Mother was told it was a sore muscle and inflammation. Mother took patient to Chiropractor 7/25/23. Mother called our clinic for first time to inform us of the issue her daughter was having 7/25/23 and requested a referral be done. Patient set up for follow-up and referral 7/26/23.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Breakthrough Covid Infection
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough Covid Infection
Age: 4.0
Sex: F
Vaccine: MMR, MMRV
Symptoms: No adverse event, Product dose omission in error, Wrong product administered
Clinical narrative: No adverse affects reported; the lot number documentation is accurate and the patient was administered MMR II, the patient will need "catch up" vaccines due to the assumption that she received her second and final dose of PROQUAD, not MMR II as document/ patient missing vaccines; The documentation of the vaccine/lot number was as MMR II and administered to a 14-year-old patient. The patient/guardian were under the impression the vaccine administered and associated with this lot number was the 2nd dose of PROQUAD, not MMR II; This spontaneous report was received from a pharmacist and refers to a 4-year-old female patient. The patient's concurrent and historical conditions, previous drugs reactions, and concomitant therapies were not reported.   On an unknown date, the patient was vaccinated with the first dose of with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, administered for prophylaxis (dose, lot #, expiry date, and route of administration were not provided). Then, on an unspecified date in February 2014, the patient received a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter, administered subcutaneously, lot # J004204 with an expiration date on 12-APR-2015 (which was documented in the vaccine database), for prophylaxis (wrong product administered).  The patient's guardians were under the impression the vaccine administered and associated with this lot number was the second dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), not measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II). Therefore, the patient would need "catch up" vaccines due to the assumption that she received her second and final dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), not measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) as documented (product dose omission in error). No adverse affects reported.
Sex: U
Vaccine: VARZOS
Symptoms: Chills, Dizziness, Gait disturbance, Headache, Illness
Clinical narrative: barely walk; chills; sick; nauseous; headache; temperature; body soreness; dizzy; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of walking difficulty in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced walking difficulty (Verbatim: barely walk), chills (Verbatim: chills), sickness (Verbatim: sick), nausea (Verbatim: nauseous), headache (Verbatim: headache), fever (Verbatim: temperature), general body pain (Verbatim: body soreness) and dizziness (Verbatim: dizzy). The outcome of the walking difficulty, chills, sickness, nausea, headache, fever, general body pain and dizziness were not reported.   It was unknown if the reporter considered the walking difficulty, chills, sickness, nausea, headache, fever, general body pain and dizziness to be related to Shingles vaccine.     It was unknown if the company considered the walking difficulty, chills, sickness, nausea, headache, fever, general body pain and dizziness to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 24-JUL-2023 The case was received from the patient via interactive digital media. The patient just got second Shingles shot and stated he/she did not know if it was worth it. The patient had been sick since middle of the night. nauseous, headache, chills, temperature, body soreness and so dizzy that he/she could barely walk.  The patient stated better be worth this shot to not get shingles.
Sex: U
Vaccine: VARZOS
Symptoms: Malaise, Nausea, Pain, Pyrexia
Clinical narrative: barely walk; chills; sick; nauseous; headache; temperature; body soreness; dizzy; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of walking difficulty in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced walking difficulty (Verbatim: barely walk), chills (Verbatim: chills), sickness (Verbatim: sick), nausea (Verbatim: nauseous), headache (Verbatim: headache), fever (Verbatim: temperature), general body pain (Verbatim: body soreness) and dizziness (Verbatim: dizzy). The outcome of the walking difficulty, chills, sickness, nausea, headache, fever, general body pain and dizziness were not reported.   It was unknown if the reporter considered the walking difficulty, chills, sickness, nausea, headache, fever, general body pain and dizziness to be related to Shingles vaccine.     It was unknown if the company considered the walking difficulty, chills, sickness, nausea, headache, fever, general body pain and dizziness to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 24-JUL-2023 The case was received from the patient via interactive digital media. The patient just got second Shingles shot and stated he/she did not know if it was worth it. The patient had been sick since middle of the night. nauseous, headache, chills, temperature, body soreness and so dizzy that he/she could barely walk.  The patient stated better be worth this shot to not get shingles.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 immunisation, SARS-CoV-2 test, Vaccination failure
Clinical narrative: CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient via another pharmaceutical company (Pfizer Inc.) concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: allergy (with unspecified drug). The patient was not taking any other medications/products within 2 weeks of starting covid-19 treatment (with Paxlovid). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number and expiry date were not reported) dose was not reported, 1 total, administered at left arm on an unspecified date in APR-2021 09:00 am for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The patient additionally received Pfizer Biontech covid-19 vaccine (tozinameran) (Dose number in series 2) (form of admin and route of admin was not reported, batch number and expiry were not reported) dose was not reported, administered at left arm on 22-SEP-2022 17:15 pm for covid-19 prophylaxis which was associated with revaccination with different covid-19 vaccine (dose number in series 2). On an unspecified date in 2023, the patient experienced covid-19 infection (confirmed covid-19 infection) (Dose number in series 2) which resulted in confirmed clinical vaccination failure (dose number in series 1) for which the patient received Paxlovid drug (nirmatrelvir/ritonavir) (form of admin, route of admin, batch number and expiry date were not reported) dose and frequency were not reported received from 05-JUL-2023 to 10-JUL-2023 for covid-19 treatment. On an unspecified date in JUL-2023, Laboratory data included: COVID-19 virus test Negative. Patient reported as 14 days after testing negative for covid and at the end of Paxlovid treatment, on 16-JUL-2023 the patient tested positive and reexperienced the symptoms. The action taken with covid-19 vaccine ad26.cov2.s, and tozinameran was not applicable. The patient was recovering from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure and revaccination with different covid-19 vaccine was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint and reference number requested.; Sender's Comments: V0: 20230751693- confirmed clinical vaccination failure. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: SPECIAL SITUATIONS. Therefore, this event is considered inconsistent with vaccine administration.
Age: 86.0
Sex: U
Vaccine: HEPA
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: accidently administered an 83 year old patient a pediatric dose; no adverse event; This spontaneous report was received from an other refers to a 86-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 24-JUL-2023, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA), 0.5 milliliter (lot #, expiration date, route of administration and anatomical location were not reported) for prophylaxis.   It was reported that on 24-JUL-2023 a nurse accidently administered an 83-year-old patient a pediatric dose of hepatitis a vaccine, inactivated (VAQTA) (product administered to patient of inappropriate age). No additional adverse event reported (no adverse event).
Age: 97.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Respiratory distress
Clinical narrative: resp distress, covid infection
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Reversible ischaemic neurological deficit, Symptom recurrence
Clinical narrative: REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 1/26/2023 --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 1.92
Sex: M
Vaccine: COVID19-2
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Patient received a 6 month to 4 year Pfizer Bivalent booster on 7/27/23. Patient tolerated vaccine well and waited 15 minutes post vaccine with no adverse reactions noted.  Patient received 6 month to 5 year Moderna for the primary series on 11/8/22 and 1/26/23. Attempted to notify mother of child of adverse event on 7/27/23.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Dizziness, Feeling cold, Loss of personal independence in daily activities, Mobility decreased
Clinical narrative: per patient:  Extreme cold chills, fever , dizziness and swollen hands & face   Spent full day Tuesday in the bed. Got up after 4pm , showered but too dizzy to accomplish anything ~ got back in the bed
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Peripheral swelling, Pyrexia, Swelling face
Clinical narrative: per patient:  Extreme cold chills, fever , dizziness and swollen hands & face   Spent full day Tuesday in the bed. Got up after 4pm , showered but too dizzy to accomplish anything ~ got back in the bed
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Inflammation, Lymphadenopathy, Mesenteric vein thrombosis
Clinical narrative: I have a completely occluded inferior mesenteric vein, completely closed off by a large blood clot.  This was caused by the Moderna vaccine and it's spike protein.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mesenteric venous occlusion, Vein disorder
Clinical narrative: I have a completely occluded inferior mesenteric vein, completely closed off by a large blood clot.  This was caused by the Moderna vaccine and it's spike protein.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalized with covid; fully vaccinated with 2 boosters
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Subclavian steal syndrome
Clinical narrative: LEFT SUBCLAVIAN STEAL SYNDROME
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough Covid Infection
Age: 23.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site pruritus, Urticaria
Clinical narrative: 21 hours after vaccine, developed hives and itching at injection site, wrist and torso (bra line). no other sx
Age: 14.0
Sex: F
Vaccine: HEPA
Symptoms: Wrong product administered
Clinical narrative: Patient was given Hep A Havrix Adult and should of been given Hep A Vaqta pediatric dose. Dr is aware and patient's parents are aware.
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Expired product administered
Clinical narrative: VACCINE GIVEN EXPIRED ON 7/6/2023
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Bursitis, Ultrasound scan abnormal
Clinical narrative: Patient has Subacromial/Subdeltoid bursitis confirmed by ultrasound that is not responding to treatment.
Age: 4.0
Sex: M
Vaccine: HEPA
Symptoms: Circumstance or information capable of leading to medication error
Clinical narrative: Due to incorrect shot record on file.  Patient received a dose of HAV vaccine on 7-27-23 by nurse thinking she was giving the 2nd dose.  It was discovered after administration that the shot record was incorrect and the dose received was actually the 3rd dose.
Age: 0.33
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered
Clinical narrative: Patient received an expired vaccine. Vaccine expired on 4/27/2023 and was given on 5/5/2023. Patient has been notified and will repeat vaccine.
Age: 13.0
Sex: M
Vaccine: HPV9
Symptoms: Dyspnoea, Rash pruritic, Wheezing
Clinical narrative: diffuse itchy rash, short of breath (does have h/o asthma), wheezing.  took his albuterol inhaler. went to ER. received steroid, benadryl, fluids. discharged home with short course of prednisone and benadryl.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient received 2nd Moderna vaccine 27 days after first. No adverse reaction.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough Covid infection
Age: 64.0
Sex: M
Vaccine: HEP, TDAP, TYP
Symptoms: Disturbance in attention, Dizziness, Head discomfort, Headache, Paraesthesia
Clinical narrative: Started with headache 1 week post-vaccination.  That proceeded to distal neuropathy/paresthesia  in feet, hands, and face accompanied by head pressure, problems with focusing vision, light headedness, and problems with concentration.  This is not a coincidence as I had a similar response to the first dose of a Rabies vaccine back in 2006 that was reported to VAERS.  Clearly, given the past similar reaction to the Rabies vaccine, either one of the vaccines I received, or a combination thereof, trigger the same sort of autoimmune response.  It has the hallmarks of GBS.  I am not experiencing, yet, muscle weakness or respiratory problems, just the peripheral neuropathy.
Age: 64.0
Sex: M
Vaccine: HEP, TDAP, TYP
Symptoms: Vision blurred
Clinical narrative: Started with headache 1 week post-vaccination.  That proceeded to distal neuropathy/paresthesia  in feet, hands, and face accompanied by head pressure, problems with focusing vision, light headedness, and problems with concentration.  This is not a coincidence as I had a similar response to the first dose of a Rabies vaccine back in 2006 that was reported to VAERS.  Clearly, given the past similar reaction to the Rabies vaccine, either one of the vaccines I received, or a combination thereof, trigger the same sort of autoimmune response.  It has the hallmarks of GBS.  I am not experiencing, yet, muscle weakness or respiratory problems, just the peripheral neuropathy.
Age: 46.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Expiration date was 04/10/2023 after leaving the freezer.
Age: 32.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Expiration date was 04/10/2023 after leaving ultraviolet freezer.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: STABLE ANGINA ANGINA, UNSPECIFIED
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough Covid infection
Age: 49.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered.
Age: 5.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Diarrhoea, Injection site erythema, Pain, Pyrexia
Clinical narrative: fever, diarrhea, body aches redness at injection site
Age: 13.0
Sex: M
Vaccine: MMRV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient is 13 years old.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Myalgia, Vulvovaginal dryness
Clinical narrative: Sore muscle and dryness in vagina for 3 days.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: EXTENSIVE AREA OF REDNESS, WARMTH AND SWELLING, NON TENDER ,COVERING THE LATERAL ASPECT OF THE LEFT THIGH
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: C-reactive protein, Chest pain, Pericarditis, Red blood cell sedimentation rate increased
Clinical narrative: pericarditis; initially presented to the ED with chest pain and then was ultimately referred to cardiology for further assessment. Received a course of colchicine, which was not well-tolerated by the patient due to diarrhea. This did not help to relieve symptoms, so she was started on a prednisone taper. This helped to relieve symptoms initially, but she continued to have recurrent chest pain once she was on a low dose of prednisone. Also tried the addition of high-dose aspirin, which helped temporarily but was stopped when inflammatory markers remained elevated.
Age: 12.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Nausea, Nervousness, Pallor, Syncope, Unresponsive to stimuli
Clinical narrative: Patient in office with mother to receive vaccines. Mother accepted offer for Tdap, HPV, Meningitis. Patient given Tdap and Meningitis and did well. After RN injected HPV vaccine around 4:15pm patient face turned pale, and he then fainted. His arms stiffened as he was fainting, and he was then unresponsive for about 20-30 seconds. RN laid patient back on table during event and called for help.  Additional nurse responded and helped RN to raise patient?s legs and place cold rag on patient forehead. Patient then came to and was able to tell nurse his name and explain that he was feeling shaky. Initial blood pressure about 4:20pm BP 109/89 HR 89. Patient given juice due to fact that child states that he has not eaten all day. BP check 4:30pm 90/66. Patient stated after drinking juice that he felt nauseous and vomited.  BP check 4:40 89/59 HR 74. Patient reported feeling better although his face was still pale. Mother decided to take child home. RN advised mother if patient fainted again, she should take him to ER. Mother voiced understanding. Patient walked down the hall with mother and then sat in waiting room until checked out. Mother walk out the door with child in stable condition.
Age: 12.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Vomiting
Clinical narrative: Patient in office with mother to receive vaccines. Mother accepted offer for Tdap, HPV, Meningitis. Patient given Tdap and Meningitis and did well. After RN injected HPV vaccine around 4:15pm patient face turned pale, and he then fainted. His arms stiffened as he was fainting, and he was then unresponsive for about 20-30 seconds. RN laid patient back on table during event and called for help.  Additional nurse responded and helped RN to raise patient?s legs and place cold rag on patient forehead. Patient then came to and was able to tell nurse his name and explain that he was feeling shaky. Initial blood pressure about 4:20pm BP 109/89 HR 89. Patient given juice due to fact that child states that he has not eaten all day. BP check 4:30pm 90/66. Patient stated after drinking juice that he felt nauseous and vomited.  BP check 4:40 89/59 HR 74. Patient reported feeling better although his face was still pale. Mother decided to take child home. RN advised mother if patient fainted again, she should take him to ER. Mother voiced understanding. Patient walked down the hall with mother and then sat in waiting room until checked out. Mother walk out the door with child in stable condition.
Age: 4.0
Sex: F
Vaccine: HEPA
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Hepatitis A given inadvertently 2 months early.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Extra dose administered
Clinical narrative: Patient requested Shingrix dose #2, stated she received dose #1 out of state.  Dose was given. Later discovered patient had completed the series in 2018
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Injection site cellulitis, Injection site rash, Injection site warmth, Rash erythematous
Clinical narrative: Approx 1 week after receiving the vaccine patient developed a red rash around the injection site and extending halfway down the upper arm. Patient reported rash was warm to the touch. Patient went to urgent care and was given an antibiotic for presumed cellulitis.  After 24 hrs on antibiotic, rash reportedly improving.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Patient presented to clinic on 07/24/2023 for Tdap and Meningo vaccines needed for school. Correct Tdap vaccine was pulled from inventory and given in the left deltoid. Correct Meningo vaccine was pulled from inventory around 9:30am but erroneously diluted with 0.5mL sterile water used for live vaccines and given to the patient in the right deltoid around 9:40am. Patient tolerated immunizations well. Printed 3231 for school. Mother and patient were directed to the main lobby to wait 15 minutes. Later that afternoon, around 3:15pm, RN who gave the vaccine realized she had accidentally diluted it that morning, while she was drawing up the same vaccine correctly for a different patient. RN reported to County nurse manager and described the event. RN reached out to District Immunization Coordinator and the District Nurse who was filling in while Coordinator was on vacation. District nurse reached out to the CDC and the State Immunization Program. RN waited to contact parent while a plan was devised. The overall recommendation was for the patient to be appropriately re-vaccinated with MenQuadfi as soon as possible and that the dose given would be counted as ?invalid?. RN received this information on 07/26/2023 and began reaching out to patient's mother via phone. Mother returned RN's calls on 07/28/2023. RN explained incident, significance, and importance of re-vaccinating to receive full protection. Reviewed potential side effects and immune response with mother and addressed her concerns that repeating a dose would be "too much" vaccine. Mother was understanding and agreed to have the child repeat the Menquadfi dose. Scheduled for 07/31/2023. Mother had no further questions. Patient had not experienced adverse reactions.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER  BUD
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER  BUD
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received dose #2 too early (4 months after dose #1)
Age: 0.5
Sex: F
Vaccine: DTPPVHBHPB, DTPPVHBHPB
Symptoms: Injection site erythema, Injection site rash, Injection site swelling, Irritability
Clinical narrative: Mother describe a "bouncy ball size" welt with redness and rash around the right upper leg at injection site the next morning after the vaccine was given, including fussiness.  Mother was asked if any, difficulty breathing, fever or any other symptoms. No other symptoms.  Mother gave fever reducing oral liquid drops for any discomfort. Mother claimed she (mother) also has adverse reaction in her medical history to Dtap
Age: 0.5
Sex: F
Vaccine: DTPPVHBHPB, DTPPVHBHPB
Symptoms: Injection site erythema, Injection site rash, Injection site reaction, Irritability, Urticaria
Clinical narrative: Mother describe a "bouncy ball size" welt with redness and rash around the right upper leg at injection site the next morning after the vaccine was given, including fussiness.  Mother was asked if any, difficulty breathing, fever or any other symptoms. No other symptoms.  Mother gave fever reducing oral liquid drops for any discomfort. Mother claimed she (mother) also has adverse reaction in her medical history to Dtap
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient did not report any adverse events, however patient received primary series of moderna at a different pharmacy and should not have received second shot of novavax until 4 months later.
Age: 84.0
Sex: M
Vaccine: COVID19-2
Symptoms: Erythema, Peripheral swelling, Pruritus, Urticaria
Clinical narrative: Redness, swelling and itching in bilateral hands that stopped at wrists.  Hives around midsection and back.  no issues with breathing or sob
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Administered Moderna vaccine of the wrong age group.
Age: 40.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site pain, Product preparation issue
Clinical narrative: Patient requested to have the Pfizer Adult Bivalent vaccine as she has never had the vaccine, CMA accidentally drew up the Age 5-11 year old vaccine-Bivalent instead of an Adult one, she also did not dilute the 5-11 year old vial of vaccine as she thought it was the adult vial.  She administered 0.3 ml of undiluted 5-11 yo Pfizer vaccine to pt in left arm IM. Office caught this error when doing inventory of Covid vaccines on 7/27/23 at 0800.  0836 am-this nurse (clinic manager) spoke with a inpatient pharmacist in our hospital pharmacy who gave me feedback on what to discuss with the patient about the vaccine error.   Clinic Manager (myself) called patient on 7/27/23 when the error had been determined by clinic staff and verified with CMA who gave the vaccine.  The only thing the patient reported when this nurse spoke with the patient was that her injection site was really sore, no swelling or redness noted at site per patient report.  Otherwise patient feels fine at the time that this nurse spoke with her by phone.  Informed patient to contact our office if any further questions or concerns.  Patient was very understanding by phone.
Age: 82.0
Sex: M
Vaccine: COVID19-2, FLUA4
Symptoms: Fatigue, Scan brain
Clinical narrative: Left Arm Fatigue same day, possible stroke the next day
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Guillain-Barre syndrome
Clinical narrative: GUILLAIN BARRE SYNDROME
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 4.0
Sex: M
Vaccine: HIBV, MMR, VARCEL
Symptoms: Expired product administered
Clinical narrative: Patient?s parent called reporting that on 07/25/2023, the client received an expired vaccine. Parent states the client received four shots, and while checking out, the staff realized one vaccine expired on 07/08/2023. Patient was told that the clinic would be contacting the health department on what to do and if the vaccine was still viable after it expired. The Health Department did not receive a call. Parent was concerned for their child because this is not the first time something like this has happened, and so contacted the Health Department themselves. Patient?s record has the patient receiving MMR, Varicella, Hib, and Dtap-IPV on 07/25/2023. All vaccine information reported in this form is from system. The MMR, Varicella, and Hib are entered under the clinic, but the Dtap-IPV is entered as Historical without lot# and Expiration.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 1.25
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product preparation issue
Clinical narrative: SARS-COV-2 (COVID-19) Maroon Cap bivalent vaccine, Pfizer 6mo-4y: vaccine was mixed with 1.3mL instead of 2.2mL in error. This was not noticed until after administration. No adverse events noted at time of administration. Family notified.
Age: 11.0
Sex: M
Vaccine: HPV9, TDAP
Symptoms: Loss of consciousness
Clinical narrative: Client passed out after receiving injection
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 39.0
Sex: F
Vaccine: PNC20
Symptoms: Headache, Lymph node pain, Musculoskeletal stiffness, Oropharyngeal pain, Pain in extremity
Clinical narrative: Arm pain: onset 7/26/23 PM resolving at time of report Headache: onset 7/27/23 AM worsening at time of report Sore throat/lymph node pain/neck stiffness: 7/27/23 PM and worsening at time of report. Reporting as considered rare side effect.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 12.0
Sex: M
Vaccine: COVID19-2, HPV9
Symptoms: Nausea
Clinical narrative: Patient was vaccinated with Pfizer at 1100 (R deltoid) then vaccinated with HPV at 1105. (R deltoid) Patient sat down in the waiting area and began feeling nauseous at approximately 1113. Patient was given an emesis bag and remained AAOx3 the entire time. vitals upon reaction at 1115 were: BP: 103/73, P: 95, O2: 100%.  Patient was observed playing video games on his phone at 1125. Patient did not vomit and stated he felt better at 1130. Patient left vaccination site under his own power along side his mother with no observable signs of distress or impairment.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebellar artery occlusion, Cerebellar stroke, Cerebrovascular accident
Clinical narrative: ACUTE STROKE DUE TO OCCLUSION OF RIGHT CEREBELLAR ARTERY ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 16.0
Sex: M
Vaccine: UNK
Symptoms: Loss of consciousness, Pallor, Syncope
Clinical narrative: Vasovagal Syncope. PT lost consciousness for aprox 10 seconds while leaving clinic. Pupils remained equal and reactive to light. Pt was pale. He was lowered to the floor by nurse. No injuries incurred. Upon regaining consciousness he declared that he was "fine." He was observed for another 15 minutes before leaving clinic, again stating that he was "fine".
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Ischaemic stroke, Respiratory failure, Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXIA
Age: 35.0
Sex: F
Vaccine: HEP
Symptoms: Exposure during pregnancy, No adverse event
Clinical narrative: RN gave a 1st dose of Hep B Recombinat to a 35yrs old pregnant lady with about 4 weeks, pt. had no adverse reaction or any complains and symptoms
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: ALLERGIC REACTION, INIT
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Reaction to previous exposure to any vaccine
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: red, swollen area under the vaccine site. area was about the size of a fist. Patient states the area is tender to touch.  no redness or swelling at injection site.  ibuprofen every 6 hours for next few days, until symptoms resolve
Age: 1.25
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: An medical assistant (MA) had administered the incorrect medication (Pediarix) to a patient, when the order was for Infanrix. It is understood that what occurred was that the MA pulled infanrix from the cart and gave to the doctor to confirm. Per the doctor, he saw DTaP and did give the approval to administer the medication. The MA first administered the vaccine to the patient, followed by scanning the vaccine, and learned the vaccine administered was the incorrect pne due to a hard stop upon scanning. The MA informed the doctor. The doctor notified the patient's mother that they accidentally gave Pediarix and told her that the patient received an extra Hep B vaccine. The doctor reassured her that this was at a safe interval from previous (6 months administration) and to monitor the patient for side effects of vaccine administration. The patient expressed appreciation.
Age: 6.0
Sex: F
Vaccine: DTAPHEPBIP, PNC13
Symptoms: Dizziness, Loss of consciousness, Pallor, Syncope, Vomiting
Clinical narrative: Vasovagal Syncope. Approximately 3 minutes after vaccine administration pt became pale and lost consciousness for aprox 10 seconds. Eyes were open and pupils were equal and reactive to light. Pt was sitting beside mother so injuries occurred. Upon regaining consciousness pt vomited small amount. Auscultation of lungs were clear in all fiends. pulse strong and regular at 75. Pt stated that she felt ok, that she had just gotten dizzy. She was observed for another 20 minutes before leaving clinic with her Mother at which point she stated that she felt good. Spoke with MD regarding the incident and she recommended having the family follow up with PCP to rule out any underlying illness. Call made to Mother's Cell phone, VM full. Will continue to try to reach her.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site erythema, Injection site oedema
Clinical narrative: Day 2 mother said she noticed redness and edema to site, brought patient in for evaluation. Provider observed and verbal instructions as cooling compress given with mediation (ibuprophen).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough Covid Infection
Age: 4.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Injection site haemorrhage
Clinical narrative: No adverse event - patient feeling well. FOC reports there was excessive bleeding at injection site but MA states there was none and FOC was not present at time of injection.  Pfizer COVID 19 first dose maroon top UNDILUTED 0.2mL given to patient.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Neuropathy peripheral
Clinical narrative: PERIPHERAL NEUROPATHY
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Fatigue, Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Patient with extreme fatigue day after vaccine. Large red bump at site of injection, hot to touch, hard. Arm very sore to move.
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Pain
Clinical narrative: Patient with extreme fatigue day after vaccine. Large red bump at site of injection, hot to touch, hard. Arm very sore to move.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: vial was first punctured on 7/21 at 11:12 a.m.  was used to vaccinate patient on 7/22 at 11:20 a.m.  This is over the 24 hours  that Pfizer can support  11 minutes after 24 hours was less than 1% of a 24 hour period which is likely relatively insignificant.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Symptom recurrence
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE 2/28/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Alanine aminotransferase increased, Electric shock sensation, Loss of consciousness, Mental status changes, Mobility decreased
Clinical narrative: Within two minutes of getting the shot injection I passed out while sitting outside into a bush. My uncle picked me up, however, I went into a seizure for the first time in my life. My uncle thought I was going to to die in his arms while he was holding me. I had a vivid vision experience while I was unconscious. When I came back I felt like my fingers couldn?t move (it was like the joints were sticky). In addition, I felt mentally changed and shook after that experience. I later had weird feelings in my body feeling like electric nerves strange pain in the inside joints of my knees. ^Almost like static electricity. On another note to add, I got the bad rash months before I got the first vaccine after having sex multiple times with my partner who had gotten the Jansen Vaccine (to my acknowledgment) while I was unvaccinated at that time.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: Within two minutes of getting the shot injection I passed out while sitting outside into a bush. My uncle picked me up, however, I went into a seizure for the first time in my life. My uncle thought I was going to to die in his arms while he was holding me. I had a vivid vision experience while I was unconscious. When I came back I felt like my fingers couldn?t move (it was like the joints were sticky). In addition, I felt mentally changed and shook after that experience. I later had weird feelings in my body feeling like electric nerves strange pain in the inside joints of my knees. ^Almost like static electricity. On another note to add, I got the bad rash months before I got the first vaccine after having sex multiple times with my partner who had gotten the Jansen Vaccine (to my acknowledgment) while I was unvaccinated at that time.
Age: 66.0
Sex: F
Vaccine: PNC20
Symptoms: Extra dose administered, Wrong patient
Clinical narrative: Patient received this vaccine when it was intended for her husband, resulting in an unnecessary vaccine in a series that she had already completed.
Age: 0.5
Sex: F
Vaccine: HPV9
Symptoms: Wrong patient, Wrong product administered
Clinical narrative: Patient given Gardasil by accident. Wrong vaccine administered to patient.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Syncope
Clinical narrative: Patient fainted after being given the immunization. She has a history of fainting, However, she did not disclose this information because she hasn't fainted recently from an immunization and took the first Shingrix successfully.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: PT REPORTS PAIN AT INJECTION SITE, SWELLING AND REDNESS/HEAT THAT IS SPREADING FROM THE INJECTION SITE WHICH STARTED THE DAY FOLLOWING THE SHINGRIX DOSE 1 VACCINATION.
Age: 82.0
Sex: M
Vaccine: VARZOS
Symptoms: Eyelid function disorder, Vision blurred
Clinical narrative: Lost eye function - can barely open eye. Eye can still focus, but takes a few seconds. Eyelid stays closed by itself, patient needs to physically lift eyelid with finder to open and focus eye.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Ischaemic stroke, Symptom recurrence
Clinical narrative: ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 3/16/2023  &  1/21/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Pulmonary embolism, Respiratory failure
Clinical narrative: ACUTE PULMONARY EMBOLISM CHRONIC HYPOXEMIC RESPIRATORY FAILURE